PF-04287881

DRUG2 trials

Sponsors

Pfizer

Conditions

Respiratory Tract Infections

Phase 1

Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

CompletedNCT00793000

PfizerRespiratory Tract Infections

Start: 2008-11-30End: 2009-12-31Updated: 2011-05-04

Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects

CompletedNCT01026545

PfizerRespiratory Tract Infections

Start: 2009-12-31End: 2010-07-31Updated: 2011-05-04